GS

Gurpreet Singh

Active Director Director DIN 09523477
DIN 09523477 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Gurpreet Singh

Data last updated:

Gurpreet Singh is a Director at Toil Pharma Private Limited (since 2022). The company operates in Chemicals. Toil Pharma Private Limited reported revenue of ₹98.8 Lakh (FY 2025).

DIN 09523477
Primary Designation Director
Industry Chemicals
First Appointment 28 Feb 2022
Oldest Company Age 4 yrs
Largest company Toil Pharma Private Limited · ₹98.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Toil Pharma Private Limited U24230HP2022PTC009171
Director28 Feb 20222022₹98.8 Lakh (FY 2025)Active

Board colleagues of Gurpreet Singh

NameDINCompanyDesignation
Penny09523478Toil Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Toil Pharma Private Limited
Premium access

Shareholding and investment profile for Gurpreet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurpreet Singh

Gurpreet Singh currently holds 1 directorship: Toil Pharma Private Limited (Director, since 28 Feb 2022, revenue ₹98.8 Lakh (FY 2025)).

Gurpreet Singh was first appointed on 28 Feb 2022 as Director at Toil Pharma Private Limited.

The current boards of Gurpreet Singh's companies include Penny (Toil Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available